QQQ   444.26 (-0.13%)
AAPL   171.11 (-1.27%)
MSFT   419.80 (-0.39%)
META   485.91 (-1.61%)
GOOGL   150.67 (-0.13%)
AMZN   180.18 (+0.19%)
TSLA   177.58 (-1.25%)
NVDA   906.85 (+0.48%)
NIO   4.57 (-2.14%)
AMD   181.77 (+1.21%)
BABA   72.47 (+1.23%)
T   17.63 (+0.46%)
F   13.19 (+1.00%)
MU   118.04 (-0.92%)
CGC   9.87 (+3.35%)
GE   175.31 (-2.67%)
DIS   122.62 (+1.36%)
AMC   3.69 (-14.98%)
PFE   28.02 (+0.86%)
PYPL   67.34 (+1.16%)
XOM   115.69 (+0.63%)
QQQ   444.26 (-0.13%)
AAPL   171.11 (-1.27%)
MSFT   419.80 (-0.39%)
META   485.91 (-1.61%)
GOOGL   150.67 (-0.13%)
AMZN   180.18 (+0.19%)
TSLA   177.58 (-1.25%)
NVDA   906.85 (+0.48%)
NIO   4.57 (-2.14%)
AMD   181.77 (+1.21%)
BABA   72.47 (+1.23%)
T   17.63 (+0.46%)
F   13.19 (+1.00%)
MU   118.04 (-0.92%)
CGC   9.87 (+3.35%)
GE   175.31 (-2.67%)
DIS   122.62 (+1.36%)
AMC   3.69 (-14.98%)
PFE   28.02 (+0.86%)
PYPL   67.34 (+1.16%)
XOM   115.69 (+0.63%)
QQQ   444.26 (-0.13%)
AAPL   171.11 (-1.27%)
MSFT   419.80 (-0.39%)
META   485.91 (-1.61%)
GOOGL   150.67 (-0.13%)
AMZN   180.18 (+0.19%)
TSLA   177.58 (-1.25%)
NVDA   906.85 (+0.48%)
NIO   4.57 (-2.14%)
AMD   181.77 (+1.21%)
BABA   72.47 (+1.23%)
T   17.63 (+0.46%)
F   13.19 (+1.00%)
MU   118.04 (-0.92%)
CGC   9.87 (+3.35%)
GE   175.31 (-2.67%)
DIS   122.62 (+1.36%)
AMC   3.69 (-14.98%)
PFE   28.02 (+0.86%)
PYPL   67.34 (+1.16%)
XOM   115.69 (+0.63%)
QQQ   444.26 (-0.13%)
AAPL   171.11 (-1.27%)
MSFT   419.80 (-0.39%)
META   485.91 (-1.61%)
GOOGL   150.67 (-0.13%)
AMZN   180.18 (+0.19%)
TSLA   177.58 (-1.25%)
NVDA   906.85 (+0.48%)
NIO   4.57 (-2.14%)
AMD   181.77 (+1.21%)
BABA   72.47 (+1.23%)
T   17.63 (+0.46%)
F   13.19 (+1.00%)
MU   118.04 (-0.92%)
CGC   9.87 (+3.35%)
GE   175.31 (-2.67%)
DIS   122.62 (+1.36%)
AMC   3.69 (-14.98%)
PFE   28.02 (+0.86%)
PYPL   67.34 (+1.16%)
XOM   115.69 (+0.63%)
NASDAQ:RVLP

RVL Pharmaceuticals (RVLP) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.00
$0.19
52-Week Range
N/A
Volume
63.96 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50
RVLP stock logo

About RVL Pharmaceuticals Stock (NASDAQ:RVLP)

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

RVLP Stock News Headlines

RVLPQ RVL Pharmaceuticals plc
RVL Pharmaceuticals PLC RVLPQ
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
RVL Pharmaceuticals Subsidiaries File for Bankruptcy
Why Is RVL Pharmaceuticals (RVLP) Stock Up 28% Today?
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
RVL Pharmaceuticals (RVLP) Gets a Buy from H.C. Wainwright
RVLP: Second Quarter Results
Q2 2023 RVL Pharmaceuticals PLC Earnings Call
See More Headlines
Receive RVLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RVL Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/20/2023
Today
3/28/2024
Next Earnings (Estimated)
4/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:RVLP
Fax
N/A
Employees
125
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.50
High Stock Price Target
$3.00
Low Stock Price Target
$2.00
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-51,690,000.00
Net Margins
-184.91%
Pretax Margin
-185.66%

Debt

Sales & Book Value

Annual Sales
$49.72 million
Book Value
$0.51 per share

Miscellaneous

Free Float
106,504,000
Optionable
Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Brian A. Markison (Age 64)
    Chairman, President, CEO & Principal Financial Officer
    Comp: $525k
  • Mr. James D. Schaub (Age 41)
    Executive VP & COO
    Comp: $367.2k
  • Mr. Christopher A. Klein (Age 58)
    General Counsel & Secretary
    Comp: $367.2k
  • Mr. Michael J. DePetris (Age 46)
    Principal Accounting Officer
  • Mr. Jarret Miller
    Executive Vice President of Human Resources

RVLP Stock Analysis - Frequently Asked Questions

Should I buy or sell RVL Pharmaceuticals stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RVL Pharmaceuticals in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" RVLP shares.
View RVLP analyst ratings
or view top-rated stocks.

What is RVL Pharmaceuticals' stock price target for 2024?

1 brokerages have issued 12 month price objectives for RVL Pharmaceuticals' shares. Their RVLP share price targets range from $2.00 to $3.00. On average, they predict the company's share price to reach $2.50 in the next year.
View analysts price targets for RVLP
or view top-rated stocks among Wall Street analysts.

When is RVL Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 1st 2024.
View our RVLP earnings forecast
.

How were RVL Pharmaceuticals' earnings last quarter?

RVL Pharmaceuticals plc (NASDAQ:RVLP) released its quarterly earnings data on Monday, March, 20th. The company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by $0.03. The firm earned $9.81 million during the quarter, compared to the consensus estimate of $12.10 million. RVL Pharmaceuticals had a negative trailing twelve-month return on equity of 130.22% and a negative net margin of 184.91%. During the same period in the prior year, the company posted ($0.26) EPS.

This page (NASDAQ:RVLP) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners